Girish N. Aakalu serves as Executive at GENOCEA BIOSCIENCES, INC., where they oversee executive responsibilities. Since joining the company, Girish N. Aakalu has executed 8 insider transactions totaling $7.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 4, 2022 involved selling 963 shares valued at $1.2K.
Girish N. Aakalu currently holds 74,459 shares of GENOCEA BIOSCIENCES, INC. (GNCA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Girish N. Aakalu has been a net seller of GNCA stock. They have purchased $0 and sold $7.5K worth of shares.
Girish N. Aakalu's most recent insider trade was on Apr 4, 2022, when they sold 963 shares at $1.25 per share.
Get notified when new Form 4 filings are submitted
| $1.10 |
| Discretionary |
| Mar 15, 2022 | GNCA | $0 | Award | 31,250 | $N/A | Discretionary |
| Jun 1, 2021 | GNCA | $1.1K | Sale | 511 | $2.23 | Discretionary |
| Apr 2, 2021 | GNCA | $2.5K | Sale | 925 | $2.71 | Discretionary |
| Mar 15, 2021 | GNCA | $0 | Award | 31,250 | $N/A | Discretionary |
| Jun 1, 2020 | GNCA | $0 | Award | 6,623 | $N/A | Discretionary |
| Apr 2, 2020 | GNCA | $0 | Award | 12,299 | $N/A | Discretionary |